Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.7 |
mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.01 | 0.7 |
mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.7 |
mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |